Jeff Marrazzo, Spark CEO

Roche's Spark in­vests $575M for new gene ther­a­py cen­ter in cen­tral Philadel­phia as part of Drex­el part­ner­ship

Roche’s Spark Ther­a­peu­tics is tak­ing a big new step in gene ther­a­py de­vel­op­ment, a field where it’s known as an ear­ly pi­o­neer.

Spark will in­vest …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.